Kodawire — SEE EVERY SIDE. KNOW THE TRUTH.Kodawire — SEE EVERY SIDE. KNOW THE TRUTH.Home
Log in
HomeWorldPoliticsBusinessTechHealthScienceClimateEducation
Kodawire — SEE EVERY SIDE. KNOW THE TRUTH.Kodawire — SEE EVERY SIDE. KNOW THE TRUTH.

Balanced coverage of the week's biggest story. See every side. Know the truth.

By signing up for the Story of the Week newsletter you agree to our privacy policy.

Product

  • For You
  • Trending
  • Blindspot
  • Local
  • Compare
  • Brief
  • Trust

Topics

  • World
  • Politics
  • Business
  • Tech
  • Health
  • Science

Regions

  • Africa
  • Europe
  • Asia-Pacific
  • Americas
  • Middle East

Company

  • About
  • Contact
  • All topics
  • My Bias
  • Privacy
  • Terms & DMCA
  • Partner Offers

KODAWIRE

KODAWIRE

© 2026 Kodawire

AboutContactPrivacyTermsTop
/
/
Back

CATIE | Ottawa scientists explore the use of long-acting cabotegravir + rilpivirine in pregnancy

1 sources

European AIDS Treatment Group3h ago

Center

CATIE | Ottawa scientists explore the use of long-acting cabotegravir + rilpivirine in pregnancy

Long-acting HIV treatment with cabotegravir + rilpivirine is an option for some people; Researchers found promising results in pregnancy when oral therapy alone was not an option.

Original

Spectrum

L 0%C 100%R 0%